FDA consumer update
For years health care providers and pharmacies have sold ear drops that contain ingredients like benzocaine and hydrocortisone that have not been evaluated for safety and effectiveness by the US Food and Drug Administration (FDA).
Now the FDA notifying companies to stop marketing 16 unapproved prescription drugs labeled to relieve ear pain and swelling.
FDA wants to make sure that the next time your child has ear pain requiring a prescription drug, the product has been approved by FDA as safe and effective.
“If we don’t know whether these drugs have any benefits, we should not accept any possible risk of side effects,” says FDA’s Charles E. Lee, M.D. Continue reading